Spire Wealth Management sells 6,389 shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA)


Spire Wealth Management lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get Rating) by 82.4% during the first quarter, according to its latest filing with the Securities & Exchange Commission. The fund held 1,362 shares of the drugstore operator after selling 6,389 shares during the period. Spire Wealth Management’s holdings in Walgreens Boots Alliance were worth $57,000 at the end of the last reporting period.

A number of other hedge funds have also recently changed their stock holdings. Rise Advisors LLC purchased a new stake in Walgreens Boots Alliance stock in Q4 valued at approximately $27,000. Iron Horse Wealth Management LLC increased its position in Walgreens Boots Alliance shares by 56.0% in the 1st quarter. Iron Horse Wealth Management LLC now owns 635 shares of the drugstore operator valued at $28,000 after buying 228 additional shares in the last quarter. City State Bank bought a new stake in Walgreens Boots Alliance stock in Q4, valued at around $30,000. Outfitter Financial LLC purchased a new stake in Walgreens Boots Alliance stock in Q4 valued at approximately $31,000. Finally, West Bancorporation Inc. purchased a new stake in Walgreens Boots Alliance stock in Q4, valued at approximately $34,000. Institutional investors and hedge funds hold 57.02% of the company’s shares.

WBA stock opened at $37.55 on Friday. The stock’s 50-day simple moving average is $41.67 and its 200-day simple moving average is $46.07. Walgreens Boots Alliance, Inc. has a fifty-two week minimum of $36.97 and a fifty-two week maximum of $55.00. The company has a debt ratio of 0.35, a quick ratio of 0.43 and a current ratio of 0.78. The company has a market capitalization of $32.45 billion, a P/E ratio of 6.06, a price-to-earnings growth ratio of 1.50 and a beta of 0.60.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last released its quarterly results on Thursday, June 30. The drugstore operator reported earnings per share of $0.96 for the quarter, meeting analyst consensus estimates of $0.96. The company posted revenue of $32.60 billion for the quarter, versus a consensus estimate of $32.23 billion. Walgreens Boots Alliance achieved a return on equity of 16.20% and a net margin of 4.00%. The company’s revenue for the quarter was down 4.2% year over year. During the same period of the previous year, the company achieved EPS of $1.51. Stock analysts predict that Walgreens Boots Alliance, Inc. will post earnings per share of 5.03 for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, June 10. Investors of record on Friday, May 20 received a dividend of $0.4775 per share. The ex-dividend date was Thursday, May 19. This represents an annualized dividend of $1.91 and a dividend yield of 5.09%. Walgreens Boots Alliance payout ratio is 30.81%.

In other Walgreens Boots Alliance news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the company in a transaction on Wednesday, May 11. The stock was sold at an average price of $150.00, for a total transaction of $900,000,000.00. Following the transaction, the insider now directly owns 52,854,867 shares of the company, valued at approximately $7,928,230,050. The sale was disclosed in a document filed with the SEC, which is available via this hyperlink. Company insiders own 17.40% of the company’s shares.

A number of research companies commented on WBA. JPMorgan Chase & Co. cut its price target on Walgreens Boots Alliance from $52.00 to $45.00 and set a “neutral” rating on the stock in a research report on Friday. Barclays lowered its price target on Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating on the stock in a Friday June 24 research note. Cowen lowered his price target on Walgreens Boots Alliance from $55.00 to $50.00 in a Tuesday, April 12 research note. UBS Group lowered its price target on Walgreens Boots Alliance from $52.00 to $49.00 and set a “neutral” rating on the stock in a Tuesday, April 5 research note. Finally, Credit Suisse Group lowered its price target on Walgreens Boots Alliance from $52.00 to $43.00 and set a “neutral” rating on the stock in a Friday, July 1 research note. One equity research analyst gave the stock a sell rating and nine gave the company a hold rating. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $46.25.

About Walgreens Boots Alliance (Get an assessment)

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail business. It operates through two segments, United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumer and general merchandise through its pharmacies Retail.

See also

Want to see what other hedge funds hold WBA? Visit HoldingsChannel.com for the latest 13F filings and insider trading for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating).

Institutional ownership by quarter for Walgreens Boots Alliance (NASDAQ:WBA)



Get news and reviews for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s free daily email newsletter.

Comments are closed.